Reply

We appreciate the questions raised by Dr Nguyen about our clinical trial evaluating the safety and efficacy of intravenous umbilical cord blood infusion for the treatment of children with autism spectrum disorder (ASD). We did not target CD34 dosing in this clinical trial because our preclinical studies and early phase clinical trial data in children with ASD and children with cerebral palsy (CP) did not show any association between improvement and CD34 dosing.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Letters to the Editor Source Type: research